Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 Mar;41(3):426-433.
doi: 10.2337/dc17-1118. Epub 2017 Sep 20.

Cumulative Kidney Complication Risk by 50 Years of Type 1 Diabetes: The Effects of Sex, Age, and Calendar Year at Onset

Tina Costacou  1 , Trevor J Orchard  2
Affiliations

Cumulative Kidney Complication Risk by 50 Years of Type 1 Diabetes: The Effects of Sex, Age, and Calendar Year at Onset

Tina Costacou et al. Diabetes Care. 2018 Mar.

Abstract

Objective: A common belief is that only a minority of patients with type 1 diabetes (T1D) develop advanced kidney disease and that incidence is higher among men and lower in those diagnosed at a younger age. However, because few patients with T1D survived to older ages until recently, long-term risks have been unclear.

Research design and methods: We examined the 50-year cumulative kidney complication risk in a childhood-onset T1D cohort diagnosed during 1950-80 (n = 932; mean baseline age 29 years, duration 19 years). Participants comprised 144 who died prior to baseline, 130 followed with periodic surveys, and 658 followed with biennial surveys and a maximum of nine examinations for 25 years. Micro- and macroalbuminuria were defined as an albumin excretion rate of 20-199 and ≥200 μg/min, respectively, and end-stage renal disease (ESRD) was defined as dialysis or kidney transplantation. Cumulative incidence was estimated at 10-year intervals between 20 and 50 years, duration and compared by calendar year of diabetes onset.

Results: By 50 years, T1D duration, ESRD affected 60% of the cohort; macroalbuminuria, 72%; and microalbuminuria, 88%. Little evidence existed for declines in cumulative incidence in recent cohorts, except for ESRD (microalbuminuria 3% increase, macroalbuminuria no change; ESRD 45% decrease by 40 years of T1D duration). Onset before age 6 years was associated with the lowest risk; incidence generally did not differ by sex.

Conclusions: Some degree of kidney disease in T1D is virtually universal at long durations and not declining, which has major implications for formulating health care and research strategies. ESRD has declined, but continues to affect >25% of the population by 40 years, duration.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Cumulative incidence of kidney complications by duration of T1D, age at onset (AON), diagnosis cohort, and sex. A: Cumulative incidence of microalbuminuria (A), macroalbuminuria (B), ESRD (C), and ESRD/mortality (D) by AON and duration of T1D. Cumulative incidence of microalbuminuria (E), macroalbuminuria (F), ESRD (G), and ESRD/mortality (H) by sex and diagnosis cohort at 30 and 40 years of T1D duration. yrs, years.
Figure 1
Figure 1
Cumulative incidence of kidney complications by duration of T1D, age at onset (AON), diagnosis cohort, and sex. A: Cumulative incidence of microalbuminuria (A), macroalbuminuria (B), ESRD (C), and ESRD/mortality (D) by AON and duration of T1D. Cumulative incidence of microalbuminuria (E), macroalbuminuria (F), ESRD (G), and ESRD/mortality (H) by sex and diagnosis cohort at 30 and 40 years of T1D duration. yrs, years.
See this image and copyright information in PMC

Comment in

References

    1. Hovind P, Tarnow L, Rossing K, et al. . Decreasing incidence of severe diabetic microangiopathy in type 1 diabetes. Diabetes Care 2003;26:1258–1264 - PubMed
    1. Brenner BM, Cooper ME, de Zeeuw D, et al. .; RENAAL Study Investigators . Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy. N Engl J Med 2001;345:861–869 - PubMed
    1. Lewis EJ, Hunsicker LG, Bain RP, Rohde RD; The Collaborative Study Group . The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy [published correction appears in N Engl Med 1993;330:152]. N Engl J Med 1993;329:1456–1462 - PubMed
    1. Lewis EJ, Hunsicker LG, Clarke WR, et al. .; Collaborative Study Group . Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes. N Engl J Med 2001;345:851–860 - PubMed
    1. Parving HH, Jacobsen P, Rossing K, Smidt UM, Hommel E, Rossing P. Benefits of long-term antihypertensive treatment on prognosis in diabetic nephropathy. Kidney Int 1996;49:1778–1782 - PubMed

Publication types

MeSH terms